SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-08-033882
Filing Date
2008-06-05
Accepted
2008-06-05 17:00:48
Documents
8
Period of Report
2008-06-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v116643_8-k.htm 8-K 29606
2 v116643_ex10-1.htm EX-10.1 1271
3 GRAPHIC v116643_ex10-1x1x1.jpg GRAPHIC 100822
4 GRAPHIC v116643_ex10-1x2x1.jpg GRAPHIC 121157
5 GRAPHIC v116643_ex10-1x3x1.jpg GRAPHIC 108298
6 GRAPHIC v116643_ex10-1x4x1.jpg GRAPHIC 110481
7 GRAPHIC v116643_ex10-1x5x1.jpg GRAPHIC 98711
8 GRAPHIC v116643_ex10-1x6x1.jpg GRAPHIC 34390
  Complete submission text file 0001144204-08-033882.txt   823995
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 08883655
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9